What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary areas of investigation include Immunology, Rheumatoid arthritis, Arthritis, Internal medicine and Antibody.
His Immunology study combines topics in areas such as Single-nucleotide polymorphism and Allele.
His research in Rheumatoid arthritis intersects with topics in Case-control study, Disease and Pathology.
His studies in Arthritis integrate themes in fields like Odds ratio, Genetics, PTPN22, Citrullination and Epitope.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Surgery.
His Antibody study integrates concerns from other disciplines, such as Immunohistochemistry, Vimentin, Antigen, Molecular biology and Lymphocyte.
His most cited work include:
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial (1554 citations)
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (1350 citations)
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review (1223 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Rheumatoid arthritis, Internal medicine, Arthritis and Antibody.
Lars Klareskog has researched Immunology in several fields, including Disease and Pathology.
He works mostly in the field of Rheumatoid arthritis, limiting it down to topics relating to Odds ratio and, in certain cases, Confidence interval.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology and Surgery.
His research in Arthritis intersects with topics in Autoimmune disease and Autoimmunity.
The study incorporates disciplines such as Molecular biology and In vivo in addition to Antibody.
He most often published in these fields:
- Immunology (54.67%)
- Rheumatoid arthritis (46.46%)
- Internal medicine (29.55%)
What were the highlights of his more recent work (between 2013-2021)?
- Rheumatoid arthritis (46.46%)
- Immunology (54.67%)
- Internal medicine (29.55%)
In recent papers he was focusing on the following fields of study:
Lars Klareskog mainly investigates Rheumatoid arthritis, Immunology, Internal medicine, Antibody and Autoantibody.
His Rheumatoid arthritis research focuses on subjects like Arthritis, which are linked to Acquired immune system.
Lars Klareskog usually deals with Immunology and limits it to topics linked to Allele and Genotype.
His research combines Physical therapy and Internal medicine.
His study in Antibody is interdisciplinary in nature, drawing from both Molecular biology and Citrullination.
His Autoantibody research includes elements of Peptide, Connective tissue disease and Antigen.
Between 2013 and 2021, his most popular works were:
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (1350 citations)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (242 citations)
- Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa (208 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Rheumatoid arthritis, Immunology, Antibody, Arthritis and Autoantibody are his primary areas of study.
His Rheumatoid arthritis study is concerned with the field of Internal medicine as a whole.
The study of Immunology is intertwined with the study of Allele in a number of ways.
His research integrates issues of Citrullination, Lung, Antigen and Pathology in his study of Antibody.
Lars Klareskog has included themes like Acquired immune system and Pathogenesis in his Arthritis study.
The various areas that Lars Klareskog examines in his Autoantibody study include Osteoclast, Fibrinogen, Immunity and Citrulline.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
